Synergy Empire Limited Reports Revenue Growth to $12,500 Amid Strategic Shift to Consultancy Services

Synergy Empire Limited reported its financial results for the three months ending June 30, 2024, revealing a revenue of $12,500, a significant increase from zero revenue in the same period last year. The company attributed this revenue to its new focus on consultancy services for restaurant owners, following the discontinuation of its asset leasing business after the divestiture of its subsidiaries on January 1, 2024. Despite the revenue generation, the company incurred a net loss of $12,624, slightly higher than the loss of $12,244 reported in the previous year.

The financial statements indicate a notable shift in the company's operational strategy. Following the disposal of its subsidiaries, Synergy Empire has transitioned to providing consultancy services, leveraging the expertise of its management team in the food and beverage industry. This strategic pivot aims to enhance operational efficiency for restaurant owners, with services including kitchen management and staff training. The company’s general and administrative expenses rose to $25,124 from $12,244, primarily due to increased costs associated with bad debt write-offs and professional fees.

In terms of financial position, Synergy Empire's total assets decreased to $14,558 as of June 30, 2024, down from $44,914 at the end of the previous fiscal period. The company reported total liabilities of $334,061, a reduction from $451,793, reflecting its efforts to streamline operations post-divestiture. The stockholders' equity also improved, with a deficit of $319,503 compared to $406,879 in the prior period, largely due to the issuance of new common shares.

Operationally, the company has seen a shift in its customer base, with one customer accounting for 100% of its revenue during the quarter. This concentration poses a risk, as the loss of this customer could significantly impact future revenues. The company’s cash flow from operating activities showed a negative trend, with $380,384 used in operations compared to $15,061 in the same period last year, indicating challenges in managing cash flow amidst ongoing losses.

Looking ahead, Synergy Empire has executed an Acquisition and Stock Purchase Agreement with Meluha Therapeutics Berhad, a biopharmaceutical company, which is expected to further transform its business model. This acquisition, set to be completed by March 2025, will shift the company’s focus to contract manufacturing and research in the biopharmaceutical sector. The management believes this strategic move will enhance profitability and operational efficiency, although the company acknowledges the need for additional funding to support its new direction and ongoing operations.